Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DDX55 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
mRNA | ZBED3 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | CH17-360D5.1 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
mRNA | CUL7 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
mRNA | C18orf54 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | EXD2 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
mRNA | UBE2S | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
mRNA | TP53TG3E | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
mRNA | VEGFB | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
mRNA | PAK1IP1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |